CJC-1295 + Ipamorelin

Description

Overview

This research blend pairs Ipamorelin (5mg), a selective growth hormone secretagogue acting on GHSR-1a, with CJC-1295 (5mg), a stabilized analog of growth hormone-releasing hormone. The combination is one of the most-referenced peptide pairings in research on the somatotropic axis.

Research Background

Ipamorelin and CJC-1295 act on parallel pathways of GH release: Ipamorelin via the ghrelin receptor and CJC-1295 via the GHRH receptor. Combined preparations allow investigators to study their additive and synergistic effects on pituitary GH secretion.

Storage & Handling

Store lyophilized peptide at -20°C for long-term stability. Once reconstituted with bacteriostatic water, store at 2–8°C and use within recommended timeframes. Handle under sterile laboratory conditions and avoid repeated freeze-thaw cycles.

Disclaimer:
This product is for laboratory research use only. It is not intended for human or animal consumption or for use in any diagnostic, therapeutic, or clinical applications.